Cite
HARVARD Citation
Mondello, P. et al. (2016). Lenalidomide in Relapsed or Refractory Diffuse Large B‐Cell Lymphoma: Is It a Valid Treatment Option?. Oncologist. pp. 1107-1112. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mondello, P. et al. (2016). Lenalidomide in Relapsed or Refractory Diffuse Large B‐Cell Lymphoma: Is It a Valid Treatment Option?. Oncologist. pp. 1107-1112. [Online].